Bill > HRes360

This resolution expresses support for designating the last Tuesday of April as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day", highlighting the significant health challenges related to kidney disease, particularly among Black Americans. The resolution emphasizes that kidney disease affects approximately 35.5 million Americans, with Black individuals being disproportionately impacted, representing 13% of the population but 30% of kidney failure cases. It specifically focuses on APOL1-mediated kidney disease, a genetic condition linked to variants in the APOL1 gene more common among people with Western or Central African ancestry, where an estimated 13% of Black Americans have these genetic mutations. The resolution aims to raise awareness about the potential risks, encourage genetic testing, and promote preventive measures such as regular medical check-ups, healthy diet, exercise, and medication adherence. Additionally, it notes the lack of FDA-approved treatments for AMKD while emphasizing the importance of ongoing research and clinical trials to develop potential treatments, and ultimately seeks to educate the public about this specific form of kidney disease and its potential health implications.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-resolution/360/all-info